The Contribution of Cell Bound Complement Activation Products to the Diagnosis of Systemic Lupus Erythematosus.

被引：0

作者：

Kalunian, Kenneth C. ^{[1
]}

Chatham, W. ^{[2
]}

Massarotti, Elena M. ^{[3
]}

Harris, Cole

Furie, R. A. ^{[4
]}

Buyon, Jill P. ^{[5
]}

Chakravarty, Eliza F. ^{[6
]}

Somers, Emily C. ^{[7
]}

Chitkara, Puja ^{[8
]}

Gross, Rachel L. ^{[9
]}

Kirou, Kyriakos A. ^{[10
]}

Reyes-Thomas, Joyce ^{[11
]}

Ramsey-Goldman, Rosalind ^{[12
]}

Hsieh, Christine ^{[13
]}

Putterman, Chaim ^{[11
]}

Dervieux, Thierry ^{[14
]}

Wein-Stein, A. ^{[15
]}

机构：

[1] UCSD, Sch Med, La Jolla, CA 92093 USA

[2] UAB, Arthrit Clin Intervent Program, Birmingham, AL USA

[3] Brigham & Womens Hosp, Boston, MA 02115 USA

[4] N Shore LIJ Hlth Syst, Lake Success, NY USA

[5] NYU, Sch Med, New York, NY USA

[6] Stanford Univ, Palo Alto, CA 94304 USA

[7] Univ Michigan, Ann Arbor, MI 48109 USA

[8] SDAMC, San Diego, CA USA

[9] Albert Einstein Coll Med, New York, NY USA

[10] Hosp Special Surg, Mary Kirkland Ctr Lupus Care, New York, NY 10021 USA

[11] Albert Einstein Coll Med, Bronx, NY 10467 USA

[12] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[13] Univ Chicago, Chicago, IL 60637 USA

[14] Exagen Diagnost, Albuquerque, NM USA

[15] Washington Hosp Ctr, Washington, DC 20010 USA

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

597

引用

页码：S229 / S229

页数：1

共 50 条

[1] B CELL-BOUND COMPLEMENT ACTIVATION PRODUCTS IN THE DIAGNOSIS AND MONITORING OF SYSTEMIC LUPUS ERYTHEMATOSUS
Beckmann, J.
Bartholomae, N.
Venhoff, N.
Henneke, P.
Janda, A.
Salzer, U.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 785 - 786
[2] Lymphocyte-Bound Complement Activation Products as Biomarkers for Diagnosis of Systemic Lupus Erythematosus
Liu, Chau-Ching
Kao, Amy H.
Hawkins, Douglas M.
Manzi, Susan
Sattar, Abdus
Wilson, Nicole
Ahearn, Joseph M.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2009, 2 (04): : 300 - 308
[3] Cell Bound Complement Activation Products Are Associated with Disease Activity in Systemic Lupus Erythematosus
Kalunian, Kenneth C.
Chatham, W. Winn
Massarotti, Elena M.
Reyes-Thomas, Joyce
Furie, Richard
Buyon, Jill
Somers, Emily C.
Putterman, Chaim
Gross, Rachel L.
Kirou, Kyriakos A.
Ramsey-Goldman, Rosalind
Hsieh, Christine
Dervieux, Thierry
Weinstein, A.
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S261 - S262
[4] Cell-Bound Complement Activation Products in Multi-Analyte Assay with Algorithm Aid the Diagnosis of Systemic Lupus Erythematosus
Mossell, James
Goldman, John A.
Barken, Derren
Alexander, Roberta
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[5] Measurement of Cell-Bound Complement Activation Products Enhances Diagnostic Performance in Systemic Lupus Erythematosus
Kalunian, Kenneth C.
Chatham, W. Winn
Massarotti, Elena M.
Reyes-Thomas, Joyce
Harris, Cole
Furie, Richard A.
Chitkara, Puja
Putterman, Chaim
Gross, Rachel L.
Somers, Emily C.
Kirou, Kyriakos A.
Ramsey-Goldman, Rosalind
Hsieh, Christine
Buyon, Jill P.
Dervieux, Thierry
Weinstein, Arthur
ARTHRITIS AND RHEUMATISM, 2012, 64 (12): : 4040 - 4047
[6] Probable systemic lupus erythematosus with cell-bound complement activation products (CB-CAPS)
Lamichhane, D.
Weinstein, A.
LUPUS, 2016, 25 (09) : 1050 - 1053
[7] New advances in measurement of complement activation: lessons of systemic lupus erythematosus.
Liu C.C.
Manzi S.
Danchenko N.
Ahearn J.M.
Current Rheumatology Reports, 2004, 6 (5) : 375 - 381
[8] A Multianalyte Assay Panel with Cell-bound Complement Activation Products Demonstrates Clinical Utility for the Diagnosis and Treatment of Systemic Lupus Erythematosus
Alexander, Roberta
Rey, Scott
Conklin, John
Domingues, Vinicius
Ahmed, Mansoor
Qureshi, Jazibeh
Weinstein, Arthur
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 659 - 661
[9] Cell Bound Complement Activation Products and Their Relationship to Disease Activity and Quality of Life Measures in Systemic Lupus Erythematosus
Furie, Richard
Buyon, Jill P.
Ramsey-Goldman, R.
Putterman, Chaim
Kalunian, Kenneth
O'Malley, Tyler
Conklin, John
Barken, Derren
Dervieux, Thierry
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S720 - S720
[10] Systemic lupus erythematosus and primary fibromyalgia can be distinguished by testing for cell-bound complement activation products
Wallace, Daniel J.
Silverman, Stuart L.
Conklin, John
Barken, Derren
Dervieux, Thierry
LUPUS SCIENCE & MEDICINE, 2016, 3 (01):

← 1 2 3 4 5 →